Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Liaqat Ali"'
Autor:
Haya Hussain, Shafiq Ur Rahman, S. Ahmad, Aman Ullah, Akhtar Aman, Niaz Ali, Muhammad Umar Khayam Sahibzada, Rana Liaqat Ali, Saad Alghamdi, Jahangir Khan, Azzah M. Bannunah
Publikováno v:
Brazilian Journal of Biology v.83 2023
Brazilian Journal of Biology
Instituto Internacional de Ecologia (IIE)
instacron:IIE
Brazilian Journal of Biology, Volume: 83, Article number: e250179, Published: 10 SEP 2021
Brazilian Journal of Biology, Vol 83 (2021)
Brazilian Journal of Biology
Instituto Internacional de Ecologia (IIE)
instacron:IIE
Brazilian Journal of Biology, Volume: 83, Article number: e250179, Published: 10 SEP 2021
Brazilian Journal of Biology, Vol 83 (2021)
Diabetes mellitus (DM) is a non-communicable disease throughout the world in which there is persistently high blood glucose level from the normal range. The diabetes and insulin resistance are mainly responsible for the morbidities and mortalities of
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 71, Iss 4, Pp 1248-51 (2021)
Objective: To observe the effects of nandrolone decanoateon renal tubules and its protection by punicagranatum (pomegranate) in mice. Study Design: Lab based experimental study. Place and Duration of Study: One year in Anatomy department, Army Medica
Autor:
Khan Muhammad Babar, Saleem Khan, Faiza Liaqat Ali, Hummaira Sadaf, Nazeer Ahmed, Dawood Shah, Ghulam Sarwar, Muhammad Yasir, Shahjahan Shabbir Ahmed, Mohammad Din
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 71(1(B))
Objective: To highlight the prevalence and epidemiology of New Delhi metallo-ß-lactamase-1.producers in pus samples. Methods: The cross-sectional study was conducted from April to August 2018at the Biotechnology Laboratory, Balochistan University of
Autor:
Sharmilee Gnanapavan, Meleri Jones, Liaqat Ali, David Baker, Klaus Schmierer, Angray S. Kang, Gavin Giovannoni, Luke Gammon, Georgia R. Leisegang, Gauri Saxena
Publikováno v:
Biotechniques
Aim: The humanized anti-CD52 monoclonal antibody alemtuzumab depletes lymphocytes and is currently used to treat relapsing multiple sclerosis. During treatment, anti-alemtuzumab antibodies may develop and reduce effective lymphocyte depletion in futu
Autor:
Hossam E Farag, Ibrahim A Al-Neami, Hussain I Al-Qasir, Akram S Awad, Liaqat Ali Khan, Yahya Ali Athlawy, Awaji Q Al-Nami
Publikováno v:
Indian Journal of Case Reports. :473-476
Autor:
Taoting Zhu, Jiangtao Gao, Linsong Shen, Waqar Islam, Chengzeng Zhou, Muhammad Mustafa, Liaqat Ali, Kristina Gasparovic, Liu Can, Ali Noman, Farooq Latif, Omaima Nasif
Publikováno v:
Saudi Journal of Biological Sciences, Vol 29, Iss 2, Pp 751-757 (2022)
With the progressive focus on renewable energy via biofuels production from lignocellulosic biomass, cellulases are the key enzymes that play a fundamental role in this regard. This study aims to unravel the characteristics of Thermotoga maritima MSB
Autor:
Abbas Khan, Jianjun Gui, Waqar Ahmad, Inamul Haq, Marukh Shahid, Awais Ahmed Khan, Abdullah Shah, Arsala Khan, Liaqat Ali, Zeeshan Anwar, Muhammad Safdar, Jehad Abubaker, N. Nizam Uddin, Liqiang Cao, Dong-Qing Wei, Anwar Mohammad
Publikováno v:
RSC advances. 11(48)
Continuing reports of new SARS-CoV-2 variants have caused worldwide concern and created a challenging situation for clinicians. The recently reported variant B.1.618, which possesses the E484K mutation specific to the receptor-binding domain (RBD), a
Autor:
Asma Sindhoo Nangraj, Abbas Khan, Shaheena Umbreen, Sana Sahar, Maryam Arshad, Saba Younas, Sajjad Ahmad, Shahid Ali, Syed Shujait Ali, Liaqat Ali, Dong-Qing Wei
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Pyrazinamide (PZA) is the first-line drug commonly used in treating Mycobacterium tuberculosis (Mtb) infections and reduces treatment time by 33%. This prodrug is activated and converted to an active form, Pyrazinoic acid (POA), by Pyrazinamidase (PZ
Autor:
David Baker, Meleri Jones, Gareth Pryce, Klaus Schmierer, Sharmilee Gnananpavan, Samantha Loveless, Vivek Vijay, Angray S. Kang, Gauri Saxena, Neil Robertson, Gavin Giovannoni, James Moore, Emma C. Tallantyre, Liaqat Ali, Georgia R. Leisegang
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
ObjectiveTo test the hypothesis that antidrug antibodies (ADAs) against alemtuzumab could become relevant after repeated treatments for some individuals, possibly explaining occasional treatment resistance.MethodsRecombinant alemtuzumab single-chain
Autor:
Constantin J. Pournaras, Emmanuelle Ranza, Jawad Ahmed, Aziz Qurban, Muhammad Ansar, Maleeha Azam, Omer Farooq, Mateusz Kecik, Sohail A. Paracha, Federico Santoni, Carlo Rivolta, Madhur Shetty, Raheel Qamar, Yacine Aggoun, Periklis Makrythanasis, Ilse Kern, Ariane Malclès, Waqar Muzaffar, Stylianos E. Antonarakis, Justyna Iwaszkiewicz, L. Keith Henry, Liaqat Ali, Muhammad T. Sarwar
Publikováno v:
Human Molecular Genetics, Vol. 29, No 4 (2020) pp. 618-623
In a consanguineous Pakistani family with two affected individuals, a homozygous variant Gly399Val in the eighth transmembrane domain of the taurine transporter SLC6A6 was identified resulting in a hypomorph transporting capacity of ~15% compared wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93236516b8b85a990bb421150e887bff
https://archive-ouverte.unige.ch/unige:142242
https://archive-ouverte.unige.ch/unige:142242